Zymeworks is a clinical-stage biotechnology company united in creating disruptive therapeutic platforms and impactful biotherapeutics that return patients to their loved ones, disease-free.For Patients
FDA Breakthrough Therapy DesignationNow Enrolling Patients
Powerful, versatile protein engineering platforms for highly customized therapeutics including cytotoxic anti-tumor biologics, antibody drug conjugates, and immuno-oncology therapies.
by creating tailored multifunctional therapeutics that enable enhanced efficacy and new biological approaches for treating diseases
with a modular suite of proprietary cytotoxins (cell-killing compounds), stable linkers, and conjugation technologies.
using precise antibody Fc modifications that tailor the antibody-mediated immune response
in a single, transferable, conditionally active design